ATE286399T1 - Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung - Google Patents
Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkungInfo
- Publication number
- ATE286399T1 ATE286399T1 AT98923551T AT98923551T ATE286399T1 AT E286399 T1 ATE286399 T1 AT E286399T1 AT 98923551 T AT98923551 T AT 98923551T AT 98923551 T AT98923551 T AT 98923551T AT E286399 T1 ATE286399 T1 AT E286399T1
- Authority
- AT
- Austria
- Prior art keywords
- saponin
- triterpene
- glucuronic acid
- adjuvant
- moiety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4712997P | 1997-05-20 | 1997-05-20 | |
| US8038998P | 1998-04-02 | 1998-04-02 | |
| PCT/US1998/010280 WO1998052573A1 (en) | 1997-05-20 | 1998-05-20 | Triterpene saponin analogs having adjuvant and immunostimulatory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286399T1 true ATE286399T1 (de) | 2005-01-15 |
Family
ID=26724657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98923551T ATE286399T1 (de) | 1997-05-20 | 1998-05-20 | Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5977081A (de) |
| EP (1) | EP0996451B1 (de) |
| JP (2) | JP4583511B2 (de) |
| KR (1) | KR100578317B1 (de) |
| AT (1) | ATE286399T1 (de) |
| AU (1) | AU732856B2 (de) |
| BR (1) | BR9809149A (de) |
| CA (1) | CA2290646C (de) |
| DE (1) | DE69828507T2 (de) |
| DK (1) | DK0996451T3 (de) |
| ES (1) | ES2235330T3 (de) |
| IL (2) | IL132886A0 (de) |
| NZ (1) | NZ500779A (de) |
| PT (1) | PT996451E (de) |
| WO (1) | WO1998052573A1 (de) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| US20030027818A1 (en) | 2001-04-03 | 2003-02-06 | Redmond H. Paul | Treatment of cancers |
| AU734180B2 (en) * | 1997-08-29 | 2001-06-07 | Antigenics Llc | Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US20010034330A1 (en) * | 1998-08-10 | 2001-10-25 | Charlotte Kensil | Innate immunity-stimulating compositions of CpG and saponin and methods thereof |
| JP4620251B2 (ja) | 1998-08-10 | 2011-01-26 | アンチジェニックス・インコーポレイテッド | Ｃｐｇおよびサポニンアジュバントの組成物並びにその方法 |
| US6262029B1 (en) | 1998-08-14 | 2001-07-17 | Galenica Pharmaceuticals, Inc. | Chemically modified saponins and the use thereof as adjuvants |
| EP2204186B1 (de) | 1999-02-17 | 2016-04-06 | CSL Limited | Immunogene Komplexe und damit zusammenhängende Verfahren |
| ES2267559T3 (es) | 1999-08-20 | 2007-03-16 | Sloan-Kettering Institute For Cancer Research | Glicoconjugados, glicoamino, acidos sus intermediarios y el uso de los mismos. |
| US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
| US7854934B2 (en) | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| WO2001015727A2 (en) * | 1999-09-02 | 2001-03-08 | Antigenics Inc. | Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof |
| WO2001037869A1 (en) * | 1999-11-19 | 2001-05-31 | Csl Limited | Vaccine compositions |
| US6905712B2 (en) * | 1999-12-08 | 2005-06-14 | Statens Veterinarmedicinska Anstalt | Vaccine adjuvants comprising ginseng plant extract and added aluminum salt |
| WO2001074382A1 (en) * | 2000-03-31 | 2001-10-11 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| AU6124601A (en) | 2000-05-10 | 2001-11-20 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
| US20020106368A1 (en) * | 2000-07-28 | 2002-08-08 | Adrian Bot | Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same |
| US6951847B2 (en) | 2000-09-29 | 2005-10-04 | Regents Of The University Of Minnesota | Methods of treating fungal infections using lupeol |
| MXPA03010035A (es) * | 2001-05-02 | 2004-06-30 | Purdue Research Foundation | Tratamiento y diagnostico de enfermedades mediadas por macrofagos. |
| US7361352B2 (en) * | 2001-08-15 | 2008-04-22 | Acambis, Inc. | Influenza immunogen and vaccine |
| ES2338305T3 (es) * | 2001-09-28 | 2010-05-06 | Purdue Research Foundation | Metodo de tratamiento que utiliza conjugados ligando-inmunogeno. |
| EP1467755A1 (de) * | 2001-12-21 | 2004-10-20 | Antigenics Inc. | Immunreaktive reagentien und saponine enthaltende zusammensetzungen sowie verfahren zur verwendung davon |
| US7030094B2 (en) * | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| US20030190333A1 (en) * | 2002-02-04 | 2003-10-09 | Corixa Corporation | Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| CA2477191A1 (en) * | 2002-02-04 | 2003-08-28 | Sally Mossman | Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| CA2508539A1 (en) * | 2002-12-03 | 2004-06-17 | Sloan-Kettering Institute For Cancer Research | Gp120 specific antigens and uses thereof |
| WO2004060915A2 (en) * | 2002-12-03 | 2004-07-22 | Sloan-Kettering Institute For Cancer Research | Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. |
| CA2522213A1 (en) * | 2003-04-08 | 2004-10-28 | Dante J. Marciani | Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| EP1667713A1 (de) * | 2003-09-15 | 2006-06-14 | ID Biomedical Corporation of Quebec | Masern-untereinheit-vakzine |
| WO2005040359A1 (en) * | 2003-10-23 | 2005-05-06 | Pfizer Products Inc. | Vaccine for periodontal disease |
| ES2422885T3 (es) * | 2003-12-03 | 2013-09-16 | Zoetis P Llc | Vacunación in ovo de campylobacter en especies aviares |
| WO2007092299A2 (en) * | 2006-02-03 | 2007-08-16 | Purdue Research Foundation | Targeted conjugates and radiation |
| US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
| ES2539818T3 (es) | 2007-08-02 | 2015-07-06 | Biondvax Pharmaceuticals Ltd. | Vacunas contra la gripe multiepitópicas multiméricas |
| CN101903037A (zh) * | 2007-11-15 | 2010-12-01 | 恩多塞特公司 | 施用偶合物的方法 |
| US20090186136A1 (en) * | 2008-01-18 | 2009-07-23 | Saponin Inc. | Process for seed and grain fractionation and recovery of bio-products |
| KR102256410B1 (ko) | 2008-04-08 | 2021-05-26 | 슬로안-케테링인스티튜트퍼캔서리서치 | 트리테르펜 사포닌, 그의 합성 방법, 및 그의 용도 |
| KR101701198B1 (ko) | 2008-06-19 | 2017-02-01 | 배리에이션 바이오테크놀로지스 아이엔씨. | 인플루엔자를 치료하기 위한 조성물 및 방법 |
| AU2009268349C1 (en) * | 2008-07-11 | 2015-01-22 | Sloan-Kettering Institute For Cancer Research | Glycopeptide constructs and uses thereof |
| CN102239253A (zh) | 2008-12-03 | 2011-11-09 | 普罗蒂亚维仕尼科技有限公司 | 谷氨酰tRNA合成酶（GtS）片段 |
| US20110097418A1 (en) * | 2009-05-29 | 2011-04-28 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
| JP5854559B2 (ja) | 2009-07-06 | 2016-02-09 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | 小胞を調製する方法及びこれから製造される製剤 |
| CA2803282C (en) | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
| WO2011067758A2 (en) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
| JP6050227B2 (ja) | 2010-06-11 | 2016-12-21 | スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ | 多価糖ペプチド構築物およびその使用 |
| CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
| US10736844B2 (en) | 2011-01-13 | 2020-08-11 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| MX357319B (es) | 2011-01-13 | 2018-07-04 | Variation Biotechnologies Inc | Metodo para preparar vesiculas y formulaciones producidas de las mismas. |
| AU2011360572B2 (en) | 2011-02-22 | 2017-03-02 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| WO2012154554A1 (en) * | 2011-05-06 | 2012-11-15 | Catabasis Pharmaceuticals, Inc. | Fatty acid triterpene derivatives and their uses |
| CN102329362B (zh) * | 2011-06-01 | 2012-11-21 | 福州大学 | 经聚乙二醇化学改性的熊果酸衍生物及其制备方法 |
| EP2802353A4 (de) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | Zusammensetzungen und verfahren zur behandlung von virusinfektionen |
| AU2013213345A1 (en) | 2012-01-27 | 2014-08-28 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
| WO2013128423A1 (en) | 2012-03-02 | 2013-09-06 | Institut National De La Sante Et De La Recherche Medicale | Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant |
| ES2702278T3 (es) | 2012-04-01 | 2019-02-28 | Technion Res & Dev Foundation | Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión |
| RU2015131033A (ru) | 2013-01-04 | 2017-02-09 | Оби Фарма, Инк. | Вакцины с повышенной плотностью размещения углеводного антигена и новый сапониновый адъювант |
| CN103271891B (zh) | 2013-04-28 | 2016-01-06 | 福建南方制药股份有限公司 | 人参皂苷纳米胶束及其制备方法、应用和药物组合物 |
| WO2015017280A1 (en) * | 2013-07-28 | 2015-02-05 | Qantu Therapeutics, Inc. | Vaccine formulations that induce a th2 immune response |
| JP6550072B2 (ja) | 2014-04-03 | 2019-07-24 | バイオンドバックス ファーマシューティカルズ リミテッド | 多量体マルチエピトープインフルエンザポリペプチドの組成物及びそれらの生成 |
| EP3140315A1 (de) | 2014-05-09 | 2017-03-15 | Universiteit Utrecht Holding B.V. | Neue cath2-derivate |
| EP3814299A4 (de) * | 2018-06-26 | 2022-03-16 | Nutrifield Pty Ltd | Pflanzennährstoffzusammensetzungen |
| CN110680819A (zh) * | 2018-07-06 | 2020-01-14 | 云南民族大学 | 一种三萜皂苷类化合物的应用 |
| WO2020126600A1 (en) * | 2018-12-21 | 2020-06-25 | Sapreme Technologies B.V. | Antibody-drug conjugate with improved therapeutic window |
| CA3184041A1 (en) * | 2020-06-24 | 2021-12-30 | Sapreme Technologies B.V. | Saponin derivatives for use in medicine |
| WO2022060905A1 (en) | 2020-09-15 | 2022-03-24 | The University Of Montana | Compositions and methods targeting filamentous bacteriophage |
| KR20230134485A (ko) | 2020-12-18 | 2023-09-21 | 유니버시테이트 우트레크트 홀딩 비.브이. | 선천성 면역 기억을 자극하는 cath2 유도체 |
| AU2022215418A1 (en) | 2021-02-05 | 2023-08-17 | Universiteit Utrecht Holding B.V. | Cath2 and derivatives for inhibiting streptococcus suis |
| CN114019166B (zh) * | 2021-09-27 | 2024-02-27 | 浙江省食品药品检验研究院 | 一种检测龙葵素的试纸条及其应用 |
| WO2024065107A1 (en) * | 2022-09-26 | 2024-04-04 | Powin Biomedical Co., Ltd. | Novel compositions comprising terpenoid and macromolecule, and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) * | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| JPH0832637B2 (ja) * | 1985-02-14 | 1996-03-29 | アクゾ・エヌ・ヴエー | 合成免疫原 |
| US5057540A (en) * | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US5583112A (en) * | 1987-05-29 | 1996-12-10 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
| NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| HU219808B (hu) * | 1992-06-25 | 2001-08-28 | Smithkline Beecham Biologicals S.A. | Adjuvánst tartalmazó vakcinakompozíció és eljárás annak előállítására |
| US5650398A (en) * | 1992-07-02 | 1997-07-22 | Cambridge Biotech Corporation | Drug delivery enhancement via modified saponins |
| US5273965A (en) * | 1992-07-02 | 1993-12-28 | Cambridge Biotech Corporation | Methods for enhancing drug delivery with modified saponins |
| SG48993A1 (en) * | 1992-10-01 | 1998-05-18 | Wellcome Found | Immunopotentiatory agent and physiologically acceptable salts thereof |
-
1998
- 1998-05-20 EP EP98923551A patent/EP0996451B1/de not_active Expired - Lifetime
- 1998-05-20 KR KR1019997010765A patent/KR100578317B1/ko not_active IP Right Cessation
- 1998-05-20 IL IL13288698A patent/IL132886A0/xx active IP Right Grant
- 1998-05-20 AT AT98923551T patent/ATE286399T1/de active
- 1998-05-20 BR BR9809149-2A patent/BR9809149A/pt not_active Application Discontinuation
- 1998-05-20 WO PCT/US1998/010280 patent/WO1998052573A1/en active IP Right Grant
- 1998-05-20 DK DK98923551T patent/DK0996451T3/da active
- 1998-05-20 DE DE69828507T patent/DE69828507T2/de not_active Expired - Lifetime
- 1998-05-20 ES ES98923551T patent/ES2235330T3/es not_active Expired - Lifetime
- 1998-05-20 NZ NZ500779A patent/NZ500779A/en not_active IP Right Cessation
- 1998-05-20 US US09/081,647 patent/US5977081A/en not_active Expired - Lifetime
- 1998-05-20 CA CA002290646A patent/CA2290646C/en not_active Expired - Fee Related
- 1998-05-20 JP JP55055598A patent/JP4583511B2/ja not_active Expired - Fee Related
- 1998-05-20 AU AU75818/98A patent/AU732856B2/en not_active Expired
- 1998-05-20 PT PT98923551T patent/PT996451E/pt unknown
-
1999
- 1999-11-11 IL IL132886A patent/IL132886A/en not_active IP Right Cessation
-
2010
- 2010-03-31 JP JP2010084524A patent/JP2010174031A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2235330T3 (es) | 2005-07-01 |
| US5977081A (en) | 1999-11-02 |
| WO1998052573A9 (en) | 1999-04-01 |
| DE69828507T2 (de) | 2006-01-05 |
| EP0996451A4 (de) | 2001-04-18 |
| WO1998052573A1 (en) | 1998-11-26 |
| DE69828507D1 (de) | 2005-02-10 |
| BR9809149A (pt) | 2000-08-01 |
| IL132886A0 (en) | 2001-03-19 |
| CA2290646C (en) | 2008-03-11 |
| CA2290646A1 (en) | 1998-11-26 |
| KR100578317B1 (ko) | 2006-05-11 |
| JP2002504099A (ja) | 2002-02-05 |
| AU7581898A (en) | 1998-12-11 |
| IL132886A (en) | 2007-02-11 |
| NZ500779A (en) | 2001-06-29 |
| EP0996451A1 (de) | 2000-05-03 |
| JP2010174031A (ja) | 2010-08-12 |
| DK0996451T3 (da) | 2005-05-23 |
| JP4583511B2 (ja) | 2010-11-17 |
| KR20010012802A (ko) | 2001-02-26 |
| EP0996451B1 (de) | 2005-01-05 |
| AU732856B2 (en) | 2001-05-03 |
| PT996451E (pt) | 2005-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE286399T1 (de) | Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung | |
| MX2021014965A (es) | Conjugado de saponina y vacuna o composicion farmaceutica que comprende la misma. | |
| US4764604B1 (de) | ||
| AU591309B2 (en) | Taxol derivatives, their preparation and pharmaceutical compositions containing them | |
| KR940018343A (ko) | 트리글리세라이드 | |
| CA2166204A1 (en) | Pharmaceutical compositions for sparingly soluble therapeutic agents | |
| ZA958600B (en) | Saponin preparations and uses thereof in iscoms | |
| FI943233A (fi) | Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos | |
| AU3374689A (en) | Detergent composition | |
| CA2152979A1 (en) | Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof | |
| IT8621540A0 (it) | Tensioattivi derivati da idrossiacidi bi- o tri-carbossilici. | |
| ZA200105278B (en) | Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use. | |
| ES2047916T3 (es) | Hidrogenacion de esteres de acidos carboxilicos. | |
| ES2041828T3 (es) | Procedimiento para el tratamiento de masa de celulosa conteniendo lignina, con ozono. | |
| DE3168681D1 (en) | D-homo steroids, their utilization and preparation and pharmaceutical compositions containing them | |
| KR880007069A (ko) | 트리글리세라이드 조성물 | |
| KR900013932A (ko) | 한방생약성분의 화장료용 분말 및 액기스 제조방법 | |
| GR3030852T3 (en) | Calanolide antiviral compounds, compositions and uses thereof. | |
| EP0194154A3 (de) | 2,3,4-Triacylhexosen und ihre Mischungen | |
| GR3029681T3 (en) | Uv-curing coating material and its use for porous and/or absorbent substrates | |
| IT1261828B (it) | Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico. | |
| MY105851A (en) | Sugar ester as detergency boosters | |
| El-Sayyad et al. | A phytochemical study of some Cassia species cultivated in Egypt | |
| DE69033693D1 (de) | Cytoprotektive substanzen mit ungesattigten kohlenwasserstoffresten von 16 bis 20 kohlenstoffatome | |
| CA2181445A1 (en) | Transparent or translucent soaps containing perfume compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0996451 Country of ref document: EP |